126 related articles for article (PubMed ID: 35645125)
1. Microwave ablation of non-small cell lung cancer tumors changes plasma levels of cytokines IL-2 and IFN-γ.
Xu H; Tan X; Kong Y; Huang Y; Wei Z; Ye X
J Cancer Res Ther; 2022 Apr; 18(2):532-544. PubMed ID: 35645125
[TBL] [Abstract][Full Text] [Related]
2. Effect of microwave ablation treatment of hepatic malignancies on serum cytokine levels.
Zhao J; Li Q; Muktiali M; Ren B; Hu Y; Li D; Li Z; Li D; Xie Y; Tao M; Liang R
BMC Cancer; 2020 Aug; 20(1):812. PubMed ID: 32847533
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of interferon-gamma, interleukin-6, and tumor necrosis factor-alpha in the radiation response of patients diagnosed with locally advanced non-small-cell lung cancer and glioblastoma multiforme.
Deniz ÇD; Gürbilek M; Koç M
Turk J Med Sci; 2018 Feb; 48(1):117-123. PubMed ID: 29479968
[TBL] [Abstract][Full Text] [Related]
4. Selective suppression of cytokine secretion in patients with small-cell lung cancer.
Fischer JR; Schindel M; Stein N; Lahm H; Gallati H; Krammer PH; Drings P
Ann Oncol; 1995 Nov; 6(9):921-6. PubMed ID: 8624296
[TBL] [Abstract][Full Text] [Related]
5. Potential predictive value of change in inflammatory cytokines levels subsequent to initiation of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer.
Lim JU; Yoon HK
Cytokine; 2021 Feb; 138():155363. PubMed ID: 33264749
[TBL] [Abstract][Full Text] [Related]
6. Computed tomography-guided microwave ablation for the treatment of non-small cell lung cancer patients with and without adjacent lobe invasion: A comparative study.
Xu S; Bie ZX; Li YM; Li B; Guo RQ; Li XG
Thorac Cancer; 2021 Oct; 12(20):2780-2788. PubMed ID: 34427998
[TBL] [Abstract][Full Text] [Related]
7. Advanced non small cell lung cancer: response to microwave ablation and EGFR Status.
Wei Z; Ye X; Yang X; Huang G; Li W; Wang J; Han X; Meng M; Ni Y
Eur Radiol; 2017 Apr; 27(4):1685-1694. PubMed ID: 27436020
[TBL] [Abstract][Full Text] [Related]
8. Microwave ablation enhances the systemic immune response in patients with lung cancer.
Ma F; Lin Y; Ni Z; Wang S; Zhang M; Wang X; Zhang Z; Luo X; Miao X
Oncol Lett; 2024 Mar; 27(3):106. PubMed ID: 38298427
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous thermal ablation of primary and secondary lung tumors: Comparison between microwave and radiofrequency ablation.
Aufranc V; Farouil G; Abdel-Rehim M; Smadja P; Tardieu M; Aptel S; Guibal A
Diagn Interv Imaging; 2019 Dec; 100(12):781-791. PubMed ID: 31402333
[TBL] [Abstract][Full Text] [Related]
10. Immunogenic change after percutaneous microwave ablation in pulmonary malignancies: Variation in immune cell subsets and cytokines in peripheral blood.
Zhang L; Zhang M; Wang J; Li Y; Wang T; Xia J; Feng B; Shen J
Front Immunol; 2022; 13():1069192. PubMed ID: 36569954
[TBL] [Abstract][Full Text] [Related]
11. [Effect of interleukin-7 on the anti-tumor function of CD8(+) T cells in patients with non-small cell lung cancer].
Zhang XH; Wang HM; Jin L; Chang R; Zu FC; Li FZ; Ku CY
Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2429-2433. PubMed ID: 30138989
[No Abstract] [Full Text] [Related]
12. Local microwave ablation with continued EGFR tyrosine kinase inhibitor as a treatment strategy in advanced non-small cell lung cancers that developed extra-central nervous system oligoprogressive disease during EGFR tyrosine kinase inhibitor treatment: A pilot study.
Ni Y; Bi J; Ye X; Fan W; Yu G; Yang X; Huang G; Li W; Wang J; Han X; Ni X; Wei Z; Han M; Zheng A; Meng M; Xue G; Zhang L; Wan C
Medicine (Baltimore); 2016 Jun; 95(25):e3998. PubMed ID: 27336903
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases.
Yang X; Ye X; Zheng A; Huang G; Ni X; Wang J; Han X; Li W; Wei Z
J Surg Oncol; 2014 Nov; 110(6):758-63. PubMed ID: 24965604
[TBL] [Abstract][Full Text] [Related]
14. Microwave ablation as local consolidative therapy for patients with extracranial oligometastatic EGFR-mutant non-small cell lung cancer without progression after first-line EGFR-TKIs treatment.
Ni Y; Ye X; Yang X; Huang G; Li W; Wang J; Han X; Wei Z; Meng M
J Cancer Res Clin Oncol; 2020 Jan; 146(1):197-203. PubMed ID: 31599340
[TBL] [Abstract][Full Text] [Related]
15. Serum IL-5 and IFN-
Zhao Q; Bi Y; Sun H; Xiao M
Dis Markers; 2021; 2021():5526885. PubMed ID: 34239620
[TBL] [Abstract][Full Text] [Related]
16. CT-guided percutaneous microwave ablation of pulmonary malignancies: Results in 69 cases.
Lu Q; Cao W; Huang L; Wan Y; Liu T; Cheng Q; Han Y; Li X
World J Surg Oncol; 2012 May; 10():80. PubMed ID: 22564777
[TBL] [Abstract][Full Text] [Related]
17. Effects of microwave ablation or its combination with whole-body chemotherapy on serum vascular endothelial growth factor levels in patients with stage IIIB/IV NSCLC.
Sun YH; Song PY; Guo Y; Pang M; He WN; Zhang WH; Sheng LJ
Genet Mol Res; 2015 Aug; 14(3):10015-25. PubMed ID: 26345938
[TBL] [Abstract][Full Text] [Related]
18. Enhanced antitumor efficacy through microwave ablation combined with a dendritic cell-derived exosome vaccine in hepatocellular carcinoma.
Zhong X; Zhou Y; Cao Y; Ding J; Wang P; Luo Y; Liu H; Zhu Z; Jing X
Int J Hyperthermia; 2020; 37(1):1210-1218. PubMed ID: 33100037
[TBL] [Abstract][Full Text] [Related]
19. Safety and clinical outcomes of computed tomography-guided percutaneous microwave ablation in patients aged 80 years and older with early-stage non-small cell lung cancer: A multicenter retrospective study.
Han X; Yang X; Huang G; Li C; Zhang L; Qiao Y; Wang C; Dong Y; Chen X; Feng Q; Wang C; Rong Z; Ding K; Wei Z; Ni Y; Wang J; Li W; Meng M; Ye X
Thorac Cancer; 2019 Dec; 10(12):2236-2242. PubMed ID: 31679181
[TBL] [Abstract][Full Text] [Related]
20. Salvage treatment of NSCLC recurrence after first-line chemotherapy failure: Iodine-125 seed brachytherapy or microwave ablation?
Liu B; Wang Y; Tian S; Hertzanu Y; Zhao X; Li Y
Thorac Cancer; 2020 Mar; 11(3):697-703. PubMed ID: 31995853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
